|
1
|
PPIB mutations cause severe osteogenesis imperfecta.
|
Am J Hum Genet
|
2009
|
2.16
|
|
2
|
On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics.
|
Bioinformatics
|
2009
|
1.74
|
|
3
|
Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology.
|
J Biol Chem
|
2003
|
1.56
|
|
4
|
Retracted
Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies.
|
Mult Scler Int
|
2011
|
1.26
|
|
5
|
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
|
Mol Cell Proteomics
|
2010
|
1.16
|
|
6
|
Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
|
Gastroenterology
|
2011
|
1.15
|
|
7
|
iTRAQ-based proteomics profiling reveals increased metabolic activity and cellular cross-talk in angiogenic compared with invasive glioblastoma phenotype.
|
Mol Cell Proteomics
|
2009
|
1.14
|
|
8
|
Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems.
|
Mol Cell Proteomics
|
2013
|
1.05
|
|
9
|
Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
|
Clin Biochem
|
2012
|
1.03
|
|
10
|
Molecular tests for colorectal cancer screening.
|
Clin Colorectal Cancer
|
2011
|
1.01
|
|
11
|
Proteomics strategies for target identification and biomarker discovery in cancer.
|
Front Biosci (Landmark Ed)
|
2009
|
0.99
|
|
12
|
Unravelling the nuclear matrix proteome.
|
J Proteomics
|
2008
|
0.98
|
|
13
|
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
|
Gut
|
2011
|
0.96
|
|
14
|
Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer.
|
Proteomics Clin Appl
|
2008
|
0.95
|
|
15
|
Proteomics of mouse BRCA1-deficient mammary tumors identifies DNA repair proteins with potential diagnostic and prognostic value in human breast cancer.
|
Mol Cell Proteomics
|
2012
|
0.93
|
|
16
|
Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.
|
J Proteome Res
|
2010
|
0.91
|
|
17
|
Intermittent administration of morphine alters protein expression in rat nucleus accumbens.
|
Proteomics
|
2006
|
0.89
|
|
18
|
Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
|
Expert Rev Mol Diagn
|
2012
|
0.88
|
|
19
|
An accurate paired sample test for count data.
|
Bioinformatics
|
2012
|
0.86
|
|
20
|
Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
|
Radiother Oncol
|
2011
|
0.86
|
|
21
|
Comparative proteomics analysis of caspase-9-protein complexes in untreated and cytochrome c/dATP stimulated lysates of NSCLC cells.
|
J Proteomics
|
2008
|
0.86
|
|
22
|
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.
|
Neurobiol Dis
|
2010
|
0.85
|
|
23
|
Comparison of the performance of two affinity depletion spin filters for quantitative proteomics of CSF: Evaluation of sensitivity and reproducibility of CSF analysis using GeLC-MS/MS and spectral counting.
|
Proteomics Clin Appl
|
2010
|
0.85
|
|
24
|
Carcinoma origin dictates differential skewing of monocyte function.
|
Oncoimmunology
|
2012
|
0.82
|
|
25
|
Detection of breast cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry tissue and serum protein profiling.
|
Int J Biol Markers
|
2009
|
0.82
|
|
26
|
The secretome of colon cancer stem cells contains drug-metabolizing enzymes.
|
J Proteomics
|
2013
|
0.81
|
|
27
|
Proteomics of genetically engineered mouse mammary tumors identifies fatty acid metabolism members as potential predictive markers for cisplatin resistance.
|
Mol Cell Proteomics
|
2013
|
0.81
|
|
28
|
Support vector machine approach to separate control and breast cancer serum samples.
|
Stat Appl Genet Mol Biol
|
2008
|
0.80
|
|
29
|
Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer.
|
J Cancer Res Clin Oncol
|
2011
|
0.79
|
|
30
|
Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
|
Clin Cancer Res
|
2012
|
0.79
|
|
31
|
Gene set based integrated data analysis reveals phenotypic differences in a brain cancer model.
|
PLoS One
|
2013
|
0.77
|
|
32
|
Proteomics in studying cancer stem cell biology.
|
Expert Rev Proteomics
|
2012
|
0.77
|
|
33
|
Chemoenzymatic synthesis of multivalent neoglycoconjugates carrying the helminth glycan antigen LDNF.
|
Carbohydr Res
|
2009
|
0.77
|
|
34
|
The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesis.
|
Brain Pathol
|
2011
|
0.76
|
|
35
|
MALDI-TOF serum profiling using semiautomated serum peptide capture with magnetic reversed phase (C18) beads.
|
Methods Mol Biol
|
2011
|
0.76
|
|
36
|
Synapse proteomics: current status and quantitative applications.
|
Expert Rev Proteomics
|
2008
|
0.75
|
|
37
|
Applications in brain proteomics: 8(th) HUPO Brain Proteome Project Workshop 7 October 2007, Seoul, Korea.
|
Proteomics
|
2008
|
0.75
|